Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series

Immunotherapy with immune checkpoint inhibitors (ICIs) have been reported to induce de novo or exacerbate pre-existing Myasthenia Gravis (MG). We present a single center case series of patients who developed an immune-related myasthenia gravis (irMG) related with ICIs. We performed a retrospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Marco, Carla, Simó, Marta, Alemany, Montse, Casasnovas, Carlos, Domínguez, Raúl, Vilariño, Noelia, Calvo, Mariona, Martín-Liberal, Juan, Brenes, Jesús, Sabater-Riera, Joan, Bruna, Jordi, Velasco, Roser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821391/
https://www.ncbi.nlm.nih.gov/pubmed/36614930
http://dx.doi.org/10.3390/jcm12010130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821391/
https://www.ncbi.nlm.nih.gov/pubmed/36614930
http://dx.doi.org/10.3390/jcm12010130

Ejemplares similares